Your browser doesn't support javascript.
loading
Addition of or switch to insulin therapy in people treated with glucagon-like peptide-1 receptor agonists: A real-world study in 66 583 patients.
Montvida, Olga; Klein, Kerenaftali; Kumar, Sudhesh; Khunti, Kamlesh; Paul, Sanjoy K.
Afiliação
  • Montvida O; Clinical Trials and Biostatistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Klein K; School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Faculty of Health, Queensland University of Technology, Brisbane, Australia.
  • Kumar S; Clinical Trials and Biostatistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Khunti K; Warwick Medical School, University of Warwick, and University Hospitals Coventry and Warwickshire, Coventry, UK.
  • Paul SK; Diabetes Research Centre, Leicester Diabetes Centre, University of Leicester, Leicester, UK.
Diabetes Obes Metab ; 19(1): 108-117, 2017 01.
Article em En | MEDLINE | ID: mdl-27629433
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Peçonhas / Diabetes Mellitus Tipo 2 / Liraglutida / Hipoglicemiantes / Insulina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Peçonhas / Diabetes Mellitus Tipo 2 / Liraglutida / Hipoglicemiantes / Insulina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article